Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All treatment naïve patients with diagnosis of malignancy 2. ECOG performance status 0 to 3
Exclusion criteria
Exclusion criteria: 1. Patients requiring radiotherapy intervention 2. Patients/ caregivers refuse for geriatric assessment 3. Patients refuse to give written informed consent 4. Patients having major neurological or medical disorder that impairs their ability to understand the study and give written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| geriatric vulnerabilitiesTimepoint: at 3 months, 6 months and 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of life of patientsTimepoint: at baseline, 3 months and 6 months;Chemotherapy toxicity risk assessmentTimepoint: 3 and 6 months;caregiver burdenTimepoint: at baseline;non-cancer life expectancyTimepoint: baseline;oncology related parameters: types of malignancy, staging, treatment plannedTimepoint: at baseline;treatment abandonment, lost to follow up, overall survival, and disease-free survival in these patientsTimepoint: 3 months, 6 months and 1 year;correlation of different geriatric conditions, clinical parameters, laboratory parameters with different outcomes (chemotherapy toxicity, overall survival, and quality of life) of the patientsTimepoint: 3, 6 and 12 months;impact of different individualized interventions (geriatric-assessment based, change in medical management) on different outcomes (chemotherapy toxicity, overall survival, and quality of life, patients and caregiver satisfaction)Timepoint: 3,6 and 12 months | — |
Countries
India
Contacts
AIIMS, New Delhi India